Extended-release naltrexone: good but not a panacea

被引:5
作者
Lott, David C. [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Psychiat, Chicago, IL 60612 USA
关键词
OPIOID DEPENDENCE; DOUBLE-BLIND; BUPRENORPHINE;
D O I
10.1016/S0140-6736(17)32872-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:283 / 284
页数:2
相关论文
共 14 条
[1]   A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. [J].
Johnson, RE ;
Chutuape, MA ;
Strain, EC ;
Walsh, SL ;
Stitzer, ML ;
Bigelow, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (18) :1290-1297
[2]   Adoption and Implementation of Medications in Addiction Treatment Programs [J].
Knudsen, Hannah K. ;
Abraham, Amanda J. ;
Roman, Paul M. .
JOURNAL OF ADDICTION MEDICINE, 2011, 5 (01) :21-27
[3]   Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial [J].
Krupitsky, Evgeny ;
Nunes, Edward V. ;
Ling, Walter ;
Illeperuma, Ari ;
Gastfriend, David R. ;
Silverman, Bernard L. .
LANCET, 2011, 377 (9776) :1506-1513
[4]  
Lee J D., 2017, The Lancet
[5]   NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale [J].
Lee, Joshua D. ;
Nunes, Edward V. ;
Novo, Patricia ;
Bailey, Genie L. ;
Brigham, Gregory S. ;
Cohen, Allan J. ;
Fishman, Marc ;
Ling, Walter ;
Lindblad, Robert ;
Shmueli-Blumberg, Dikla ;
Stablein, Don ;
May, Jeanine ;
Salazar, Dagmar ;
Liu, David ;
Rotrosen, John .
CONTEMPORARY CLINICAL TRIALS, 2016, 50 :253-264
[6]   Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: A very low dose naltrexone and buprenorphine open label trial [J].
Mannelli, Paolo ;
Wu, Li-Tzy ;
Peindl, Kathleen S. ;
Swartz, Marvin S. ;
Woody, George E. .
DRUG AND ALCOHOL DEPENDENCE, 2014, 138 :83-88
[7]   Oral naltrexone maintenance treatment for opioid dependence [J].
Minozzi, Silvia ;
Amato, Laura ;
Vecchi, Simona ;
Davoli, Marina ;
Kirchmayer, Ursula ;
Verster, Annette .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (04)
[8]   Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population [J].
Morgan, Jake R. ;
Schackman, Bruce R. ;
Leff, Jared A. ;
Linas, Benjamin P. ;
Walley, Alexander Y. .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 85 :90-96
[9]   Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone [J].
Nunes, Edward V. ;
Gordon, Michael ;
Friedmann, Peter D. ;
Fishman, Marc J. ;
Lee, Joshua D. ;
Chen, Donna T. ;
Hu, Mei Chen ;
Boney, Tamara Y. ;
Wilson, Donna ;
O'Brien, Charles P. .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 85 :49-55
[10]   Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015 [J].
Rudd, Rose A. ;
Seth, Puja ;
David, Felicita ;
Scholl, Lawrence .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (50-51) :1445-1452